Schering-Plough Corp. (SGP)

All Comments on SGP

  • commenter
    Apr 01 02:08 PM
    Schering-Plough: As Cheap an Entry Point as You'll Find [view article]
    SCP IS NOT CHEAP.
    They are carrying $19 billion in debt, and this disappointment will reduce their earnings for 08'
    by 40 %.
    No one wants to buy them. Yhe stock has NO catalyst to ignite the stock price.
    Reply
  • commenter
    Apr 01 01:20 PM
    Schering-Plough: As Cheap an Entry Point as You'll Find [view article]
    MDINCT, what do you think of Merck's products? Reply
  • commenter
    Apr 01 01:07 PM
    Schering-Plough: As Cheap an Entry Point as You'll Find [view article]
    I'm not sure the analysts have a clue as to what they're talking about.
    As an MD I can tell you would be hard pressed to find a doctor writing scripts for Zetia or Vytorin following this report. I can't tell you how many phone calls we've had already from patients who are looking for another drug.
    What is Schering going to make there earnings on? All of their drugs are second-in-class (PEG-Intron is being soundly beaten by Roche's Pegasys for Hep C, Remicade is being rapidly replaced by Abbott's Humira, Viagra beats Levitra, Miralax is generic, etc.) Maybe their Dr. Scholls foot product line can carry them forward. I wouldn't touch this company, expect on a takeover play.
    Reply
  • commenter
    Apr 01 09:41 AM
    Wall Street Breakfast: Must-Know News [view article]
    "Sources close to Microsoft (MSFT) say it has no plan to raise its offer for Yahoo (YHOO) -- for real. "

    This sounds to me like a gentle way to "walk away". I would be surprised if Yahoo should accept a deal which was shown to be unaccceptable and hasn't gotten any better. It's actually gotten worse.
    Reply
  • commenter
    Apr 01 08:50 AM
    My Website
    Wall Street Breakfast: Must-Know News [view article]
    there will be little or no change on wall st. it will be the same crowd running the show for their own benefit. after the election all this change talkwill be history. Reply
  • commenter
    Apr 01 01:15 AM
    Ten Companies Involved in Treating Asthma [view article]
    Alvesco, ciclesonide is marketed by Sepracor, not Sanofi-Aventis Reply
  • commenter
    Mar 31 06:22 PM
    My Website
    4 Reasons To Buy Schering-Plough On This Big Drop [view article]
    Hey Notable Calls- You could have gotten it cheaper had you waited. You said you were buying around $15.80, closed today at $14.41.... Could have saved yourself some $$$.

    Based on your previous calls, (Like ABH call 2/21 at $17 dollars, could have bought it for TEN DOLLARS eight days later!!!) I'll just wait for it to drop much much much much much more.

    Seems to be the way your calls go. Nothing personal...
    Reply
  • commenter
    Mar 31 02:25 PM
    4 Reasons To Buy Schering-Plough On This Big Drop [view article]
    the preferred is looking very juicy at these prices...

    sgp.prb

    at today's prices the preferred pays a safe 10% dividend...

    plus sgp has a blockbuster new drug coming out this summer for anesthesia reversal...suggamadex....

    i think i will buy the preferred...
    Reply
  • commenter
    Mar 31 10:43 AM
    4 Reasons To Buy Schering-Plough On This Big Drop [view article]
    Good call. Market seems to be overreacting left and right these days. Reply
  • commenter
    Mar 31 09:29 AM
    My Website
    Jim Cramer's Mad Money In-Depth, 3/28/08: Low Hopes for Earnings [view article]
    SGP up - another sterling Cramer prediction ... arg Reply
  • commenter
    Mar 31 08:47 AM
    Wall Street Breakfast: Must-Know News [view article]
    Always an early morning "oughta" read. Reply
  • commenter
    Mar 30 07:55 AM
    My Website
    Fast Money Recap, 3/27/08: Oracle a False Profit [view article]
    People who doubt Oracle have been wrong time and again... Reply
  • commenter
    Mar 29 05:14 PM
    My Website
    Fast Money Recap, 3/27/08: Oracle a False Profit [view article]
    i love that show....only thing i try to watch on cnbc. i didn't like that there were 2 Najarian's, one's enough. they should bring back "pretty boy". Karen is so hot, i would be her biatch in a minute :p Reply
  • commenter
    Mar 25 02:56 PM
    Jeffrey Saut: Large Trading Positions in Double-Long ETFs [view article]
    Jeffrey wrongly called a bottom this past January...
    While he seems to be an averagely successful market timer.. he does occasionally get things right. Not sure if this is the right call yet....
    Reply
  • commenter
    Mar 21 09:55 AM
    My Website
    Consumers Union’s Approach to Improving Drug Safety Surveillance is Misguided [view article]
    We need to be sure that we don't limit things too much and miss out on some very promising drugs. Reply